Yew Bio Pharm Income Statement - Quarterly (OTCMKTS:YEWB)

Add to My Stocks
$0.24 $0 (0%) YEWB stock closing price Jan 18, 2017 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Yew Bio Pharm stock price. The income statement is a summary of the revenue, expenses and profitability (shown as Net Income) or lack of it. The income statement for YEWB which implies a QoQ revenue decline of $1.39M is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with Yew Bio Pharm assets and Yew Bio Pharm free cash flow, profits as shown in profit and loss statement give key insights about the business. The profits have decreased from $1.31M QoQ and 2016-Q3 revenue is $14.67M. View details of revenue and profits for Yew Bio Pharm for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Yew Bio Pharm Net Sales or Revenues
14.67M16.06M8.62M17.27M5M4.67M2.64M1.9M1.7M2.06M
Cost Of Goods Sold (COGS)13.24M14.41M7.22M15.52M3.57M2.28M1.17M0.9M0.29M0.42M
Yew Bio Pharm Gross Profit
1.41M1.64M1.39M1.78M1.41M2.37M1.47M1.01M1.4M1.63M
Research & Development Expense----------
Selling General & Admin Expense0.29M0.34M0.31M0.46M0.48M0.48M0.47M0.41M0.51M0.22M
Income Before Depreciation Depletion Amortization1.11M1.3M1.07M1.32M0.93M1.89M0.99M0.61M0.89M1.41M
Depreciation Depletion Amortization----------
Non Operating Income-0.03M--0.02M0.05M-0.11M----
Interest Expense----------
Yew Bio Pharm Pretax Income
1.08M1.3M1.05M1.38M0.93M2M0.99M0.61M0.89M1.41M
Provision for Income Taxes----0.04M--0.04M---
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations1.08M1.31M1.05M1.39M0.93M2.01M0.96M0.61M0.89M1.41M
Extraordinary Items & Discontinued Operations----------
Yew Bio Pharm Net Income (Profit/Loss)
1.08M1.31M1.05M1.39M0.93M2.01M0.96M0.61M0.89M1.41M
Average Shares used to compute Diluted EPS51.89M51.88M51.88M51.88M52.19M57.62M58.23M---
Average Shares used to compute Basic EPS51.88M51.88M51.88M51.88M52.16M52.13M52.13M---
Income Before Nonrecurring Items1.08M1.31M1.05M1.39M0.93M2.01M0.96M---
Income from Nonrecurring Items----------
Yew Bio Pharm Earnings Per Share Basic Net
0.020.030.020.030.020.040.02---
Yew Bio Pharm Earnings Per Share Diluted Net
0.020.030.020.030.020.030.02---
EPS Diluted Before Nonrecurring Items0.020.030.020.030.020.030.02---
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

Before investing one should read a report on Yew Bio Pharm stock analysis. It helps to look at the following income statement items:
  • Revenue: This is the inflow that is generated from the sale of goods or services and is $14.67M for this quarter of 2016-Q3. Our Yew Bio Pharm revenue chart gives a clear visual representation of how the topline growth has been. Investors often invest in only those companies where the revenue is growing at a steady rate.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. YEWB stock had a poor bottom line growth.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Yew Bio Pharm historical stock prices to check how the price has moved with time. .

Yew Bio Pharm Income Statement - Key Financial Ratios

PE ratio (price earnings ratio)
2.4000
PS ratio (
price sales ratio
)
0.2199
Operating margin
7.6
Net profit margin
7.4
Dividend yield
0%